Defence Therapeutics Inc. (CSE:DTC)
0.2500
-0.0050 (-1.96%)
Nov 20, 2026, 3:41 PM EST
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 19.03 million as of November 20, 2026. It is the 39,285th most valuable company in the world and the 1,240th biggest in Canada. Its market cap has decreased by 59.57% in one year.
Market Cap
19.03M
Enterprise Value
18.87M
Revenue
n/a
Global Rank
Country Rank
#1,240 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 19.03M, a decrease of -78.64%. That is a compound annual growth rate of -24.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 19.03M | -53.94% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sona Nanotech | 30.70M |
| Resverlogix | 25.82M |
| Telescope Innovations | 22.63M |
| Medicenna Therapeutics | 21.23M |
| The More Life Company | 20.57M |
| Devonian Health Group | 17.52M |
| Lobe Sciences | 16.98M |
| Pharmala Biotech Holdings | 16.45M |